Clovis pays off notes, raises $40M+ in ATM offering

In an effort to clean up its balance sheet, cancer-drug manufacturer Clovis Oncology Inc. (NYSE: CLVS) has paid off $64.4 million in maturing convertible senior notes due in 2021 and raised more than $40 million in new financing through at-the-market offerings.

Find out more in the BizWest article.

Categories: Ecosystem News